These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17869234)

  • 1. Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers.
    Bogavac-Stanojević N; Ivanova Petrova G; Jelić-Ivanović Z; Memon L; Spasić S
    Clin Biochem; 2007 Nov; 40(16-17):1180-7. PubMed ID: 17869234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report.
    Schnell-Inderst P; Schwarzer R; Göhler A; Grandi N; Grabein K; Stollenwerk B; Manne J; Klauss V; Siebert U; Wasem J
    Int J Technol Assess Health Care; 2010 Jan; 26(1):30-9. PubMed ID: 20059778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and inflammatory markers for the prediction of coronary artery disease: a multi-marker approach.
    Bogavac-Stanojević N; Jelić-Ivanović Z; Spasojević-Kalimanovska V; Spasić S; Kalimanovska-Ostrić D
    Clin Biochem; 2007 Sep; 40(13-14):1000-6. PubMed ID: 17632095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease.
    Yilmaz N; Ciçek HK; Celik A; Meram I; Kocabas R; Davutoglu V
    East Mediterr Health J; 2007; 13(3):522-35. PubMed ID: 17687824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular opacification for the diagnosis of coronary artery disease with stress echocardiography: an angiographic study of incremental benefit and cost-effectiveness.
    Moir S; Shaw L; Haluska B; Jenkins C; Marwick TH
    Am Heart J; 2007 Sep; 154(3):510-8. PubMed ID: 17719299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography.
    Kreisz FP; Merlin T; Moss J; Atherton J; Hiller JE; Gericke CA
    Heart Lung Circ; 2009 Jun; 18(3):200-7. PubMed ID: 19250870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of plasma high sensitive C-reactive protein in detecting three-vessel coronary artery disease: modification by apolipoprotein E genotype.
    Mennander A; Kuukasjärvi P; Laurikka J; Nikus K; Karhunen PJ; Tarkka M; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(8):714-9. PubMed ID: 18609102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker approach for the prediction of coronary artery disease: cost-effectiveness analysis.
    Lakić D; Bogavac-Stanojević N; Jelić-Ivanović Z; Kotur-Stevuljević J; Spasić S; Kos M
    Value Health; 2010; 13(6):770-7. PubMed ID: 20667056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
    Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
    Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of plasma high-sensitive C-reactive protein and monocyte chemotactic factor-1 following percutaneous coronary interventional procedures in patients with coronary artery disease].
    Wang SL; Han YL; Liu LJ; Yan CH; Kang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1073-5. PubMed ID: 18583268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
    Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.